<SEC-DOCUMENT>0001176256-19-000342-index.html : 20191119 <SEC-HEADER>0001176256-19-000342.hdr.sgml : 20191119 <ACCEPTANCE-DATETIME>20191119145510 ACCESSION NUMBER: 0001176256-19-000342 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20191119 FILED AS OF DATE: 20191119 DATE AS OF CHANGE: 20191119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001018735 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12033 FILM NUMBER: 191230807 BUSINESS ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 BUSINESS PHONE: 1-800-936-9669 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>nymox6kmpm.htm <DESCRIPTION>REPORT OF FOREIGN ISSUER FOR THE PERIOD ENDED NOVEMBER 19, 2019 <TEXT> Document 1 - file: nymox6kmpm.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>exhibit99-1.htm <DESCRIPTION>NOTICE OF ANNUAL GENERAL MEETING ON DECEMBER 17, 2019 <TEXT> Document 2 - file: exhibit99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>3 <FILENAME>exhibit99-2.htm <DESCRIPTION>INFORMATION CIRCULAR <TEXT> Document 3 - file: exhibit99-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>4 <FILENAME>exhibit99-3.htm <DESCRIPTION>FORM OF PROXY <TEXT> Document 4 - file: exhibit99-3.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>cpulogo.jpg <TEXT> Document 5 - file: cpulogo.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>exhibit99-3x1x1.jpg <TEXT> Document 6 - file: exhibit99-3x1x1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>exhibit99-3x1x2.jpg <TEXT> Document 7 - file: exhibit99-3x1x2.jpg
</DOCUMENT> </SEC-DOCUMENT>